SGA
VIR icon

Sector Gamma AS’s Vir Biotechnology VIR Stock Holding History

Sector Gamma AS’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-148,538
Closed -$1.49M – 33
2023
Q4 		$1.49M Hold
148,538
– – 0.36% 30
2023
Q3 		$1.39M Sell
148,538
-1,868
-1% -$26.6K 0.36% 28
2023
Q2 		$3.69M Buy
150,406
+4,861
+3% +$122K 0.83% 28
2023
Q1 		$3.39M Buy
145,545
+55,737
+62% +$1.43M 0.82% 28
2022
Q4 		$2.27M Hold
89,808
– – 0.52% 30
2022
Q3 		$1.73M Sell
89,808
-20,415
-19% -$519K 0.45% 27
2022
Q2 		$2.81M Buy
110,223
+30,000
+37% +$700K 0.63% 30
2022
Q1 		$2.06M Buy
80,223
+36,223
+82% +$1.07M 0.45% 38
2021
Q4 		$1.84M Buy
+44,000
New +$1.72M 0.43% 33

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sector Gamma AS's VIR Position: Q1 2024 in Review

Sector Gamma AS sold out of Vir Biotechnology (VIR) in Q1 2024, closing a stake of 148,538 shares — an estimated $1.49M sold.

Sector Gamma AS first reported a position in VIR in Q4 2021 and held it in 9 quarters. The position peaked at $3.69M in Q2 2023. 209 funds tracked by Wall St. Rank hold VIR as of Q1 2024.

  • Sector Gamma AS reported no remaining Vir Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Sector Gamma AS sold 148,538 Vir Biotechnology shares in Q1 2024, an estimated $1.49M.
  • Sector Gamma AS first reported a position in Vir Biotechnology in Q4 2021 and held it in 9 quarters.
  • Sector Gamma AS's Vir Biotechnology position peaked at $3.69M in Q2 2023.
  • 209 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2024.

Based on Sector Gamma AS's 13F filing for Q1 2024, filed 8 May 2024.